InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Sees Large Growth in Short Interest
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 20,000 shares, a growth of 94.2% from the May 30th total of 10,300 shares. Based on an average daily volume of 16,500 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.1% of the shares of the company are short sold.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Dimensional Fund Advisors LP grew its stake in InfuSystem by 7.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 228,305 shares of the medical instruments supplier’s stock valued at $785,000 after acquiring an additional 16,065 shares during the period. FineMark National Bank & Trust grew its stake in InfuSystem by 5.9% in the 1st quarter. FineMark National Bank & Trust now owns 225,396 shares of the medical instruments supplier’s stock valued at $1,129,000 after acquiring an additional 12,500 shares during the period. White Pine Capital LLC grew its stake in InfuSystem by 26.7% in the 1st quarter. White Pine Capital LLC now owns 401,250 shares of the medical instruments supplier’s stock valued at $2,010,000 after acquiring an additional 84,575 shares during the period. Finally, Kennedy Capital Management Inc. acquired a new stake in InfuSystem in the 1st quarter valued at $3,374,000.
INFU traded down $0.15 during trading on Thursday, reaching $4.60. 1,400 shares of the company’s stock were exchanged, compared to its average volume of 23,920. InfuSystem has a 1 year low of $2.85 and a 1 year high of $5.21.
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Read More: What is a Tariff?
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.